JSR

JSR Corporation, together with its subsidiaries, is engaged in petrochemical products, fine chemicals, and other products businesses primarily in Japan, South Korea, China, Taiwan, Thailand, the United States, and Belgium. The company operates in three segments: elastomers, plastics, and fine chemicals, and other products. It offers elastomers products, such as synthetic rubbers comprising styrene-butadiene rubber, polybutadiene rubber, ethylene propylene rubber, etc.; thermoplastic elastomers and compounded products; and emulsions, including paper coating latex, styrene-butadiene latex, and acrylic emulsions. The company also offers performance chemicals, such as organic/inorganic hybrid coating materials, high-functional dispersants, industrial particles, thermal control materials, binder materials for lithium-ion batteries, etc.; other products comprising butadiene monomers, etc.; and plastics products, including ABS, AES, AS, and ASA resins. In addition, it develops and supplies semiconductor materials, which include lithography materials, such as photoresists and multilayer materials, as well as CMP materials, packaging materials, etc. Further, the company provides display materials for LCD panels, anti-reflective coatings, other functional coating materials, etc.; and optical materials, including heat-resistant transparent resin and films, UV curing optical fiber coating materials, stereo-lithography systems, etc. Additionally, it offers life sciences products, such as in-vitro diagnostics, reagents and bioprocess materials, and medical polymers, as well as lithium-ion capacitors for electricity storage. The company was formerly known as Japan Synthetic Rubber Co., Ltd. JSR Corporation was founded in 1957 and is headquartered in Tokyo, Japan.

Eric Johnson

CEO

21 past transactions

Fluence Analytics

Venture Round in 2021
Fluence Analytics is a manufacturer of industrial and laboratory systems that produce continuous data streams. These measurements, combined with powerful, proprietary analytical tools, enable realtime optimization of process control and faster R&D for polymer and biopharmaceutical manufacturers.

Vedanta Biosciences

Series D in 2021
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.

Iridia

Series B in 2021
Iridia is a nanotechnology company that specializes in biochemistry, molecular biology, and DNA. It develops the world’s first commercially-attractive, DNA-based data storage solution that combines DNA polymer synthesis technology, electronic nano-switches, and semiconductor fabrication technologies. Iridia developed a highly-parallel format to enable an array of nanomodules with the potential to store data at exceptionally high density. The company was founded in 2016 and headquartered in California, United States.

AlphaICs

Series B in 2021
Alphaics is advancing AI compute with its patented technology called RAP, which would revolutionize the autonomous systems. Alphaics owns several inventions critical to AI computing. Currently Alphaics is commercializing the RAP (Real AI Processing) for use in Self driving cars, Robotics, Intelligent cloud computing, UAV and more.

Cambridge Quantum Computing

Venture Round in 2020
CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms. In the coming period as quantum devices become more prevalent, the focus of CQCL's activity is the development of algorithms and source code.

Inpria

Series C in 2020
Inpria Corporation is a pioneer in extending semiconductor lithography with inorganic photoresists and other thin-films for nanoscale patterning. Inpria’s patented photo-condensed molecular oxides offer customers the unique ability to deposit – directly from solution – atomically smooth, intrinsically dense, and directly photopatternable metal oxide films, enabling advanced performance with simplified processing.

Carbon

Series E in 2019
Carbon provides printing solutions for products that outperform. The company helps businesses develop better products and bring them to market in less time. Carbon is a venture-backed company. They serve industries including automotive, consumer, industrial, life sciences, and dental.

Cambridge Quantum Computing

Funding Round in 2019
CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms. In the coming period as quantum devices become more prevalent, the focus of CQCL's activity is the development of algorithms and source code.

Mattrix Technologies

Series A in 2019
Mattrix Technologies develops full-aperture OLET display. OLET is a new paradigm for emissive displays that circumvents the OLED backplane problem that has prevented widespread adoption of OLED displays.

Vedanta Biosciences

Series C in 2019
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.

FLOSFIA

Corporate Round in 2019
FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.

Absci

Series D in 2019
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

Cambridge Quantum Computing

Funding Round in 2018
CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms. In the coming period as quantum devices become more prevalent, the focus of CQCL's activity is the development of algorithms and source code.

Carbon

Series D in 2017
Carbon provides printing solutions for products that outperform. The company helps businesses develop better products and bring them to market in less time. Carbon is a venture-backed company. They serve industries including automotive, consumer, industrial, life sciences, and dental.

Thermalin

Series A in 2017
Thermalin hopes to disrupt the $30B insulin/insulin delivery market with a disposable, postage-stamp-sized glucose management system enabled by our first-in-class stabilized, highly concentrated, and ultra-rapid acting insulin. This same new insulin molecule in "ordinary" (U-100) concentration will enable the factory-filling of reservoirs for existing insulin pumps. In addition to this lead program, Thermalin is developing partnerships on no-cold-chain basal and mix insulins and on glucose-responsive insulins.

Lexi

Acquisition in 2017
LEXI offers 3D pre-operative planning orthopedic software for total/partial hip/knee arthroplasty and osteotomy. The software is CE-marked and FDA-cleared and produced under an ISO 13485-certified quality system and installed at 250+ medical institutions in Japan. 3D pre-operative planning improves surgeons'​ performance and patients'​ QOL(Quality Of Life). They strive to meet demands of the medical industry with advanced technology.

Inpria

Series B in 2017
Inpria Corporation is a pioneer in extending semiconductor lithography with inorganic photoresists and other thin-films for nanoscale patterning. Inpria’s patented photo-condensed molecular oxides offer customers the unique ability to deposit – directly from solution – atomically smooth, intrinsically dense, and directly photopatternable metal oxide films, enabling advanced performance with simplified processing.

Light Polymers, Inc.

Series B in 2017
The $140B Flat Panel Display Industry consumes annually $10B of optical film polarizers that require costly, time consuming stretching or messy rubbing to align the coatings in the production process. To achieve ultra high definition resolutions, smartphones and HDTV’s are designed with smaller pixel apertures, which in turn reduce the display brightness. To maintain the brightness, display engineers either use more LED’s to boost the light therefore increasing the power consumption or use thinner optical films including polarizers to re-gain light throughput. Our lyotropic liquid crystal materials eliminate these major bottlenecks, providing breakthrough, single layer, and thin, coatable polarizers either on substrates or directly on the cell eliminating the substrate using industry standard production processes. The result is a low cost, easy to make, high brightness polarizer that meets the market trends for ultra high resolutions displays.

Selexis

Acquisition in 2017
Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients.

Carbon

Series C in 2016
Carbon provides printing solutions for products that outperform. The company helps businesses develop better products and bring them to market in less time. Carbon is a venture-backed company. They serve industries including automotive, consumer, industrial, life sciences, and dental.

Lehigh Technologies

Venture Round in 2014
Lehigh Technologies is a specialty materials company that transforms end-of-life tires and other post-industrial rubber into high-performance, lower cost, sustainable micronized rubber powders (MRP). These MRPs replace oil- and rubber-based feedstocks in a wide range of industrial and consumer applications, including high performance tires, consumer and industrial plastics, consumer goods, coatings & sealants and construction materials. Lehigh tailors its PolyDyne™ and MicroDyne™ MRPs to customers’ needs to maximize benefits and optimize performance. Lehigh also offers its customers comprehensive Closed-Loop services. Lehigh Technologies operates the world’s largest MRP manufacturing plant just outside of Atlanta, with an annual production capacity of 140 million pounds. Lehigh also has the world’s leading MRP research and development facility, its Application & Development Center.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.